Briefing Industry news Industry briefing NEWS GSK to invest $1.2bn in infectious diseases R&D in lower-income countries GSK announced plans to invest $1.2bn (£1bn) over a decade to expedite research and development (R&D) for infectious diseases like malaria, tuberculosis, and other diseases in lower-income countries news Blueprint Medicines announces financing partnerships for $1.25bn Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma Briefing DiaMedica Phase II/III acute ischemic stroke trial placed on FDA clinical hold The US FDA placed DiaMedica Therapeutics’ Phase II/III DM199 clinical trial for treating patients with acute ischemic stroke (AIS) Industry news Industry briefing 07/19/2022 11:29:26
Briefing
DiaMedica Phase II/III acute ischemic stroke trial placed on FDA clinical hold
The US FDA placed DiaMedica Therapeutics’ Phase II/III DM199 clinical trial for treating patients with acute ischemic stroke (AIS)